Oncologists' perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer
Pierre Hemming, Rajneesh Kaur, Bettina Meiser, Joanne McKinley, Mary-Anne Young, Paul A James, Laura E Forrest
Journal of Community Genetics | SPRINGER HEIDELBERG | Published : 2021
Poly ADP ribose polymerase (PARP) inhibitors offer a survival advantage to women with high-grade serous ovarian cancer who have a germline BRCA1/2 pathogenic variant (PV). Yet, rates of genetic testing among this population have remained persistently low. A national, centralized telephone genetic counseling service was established in January 2016 in Australia to improve access to genetic services and facilitate BRCA1/2 testing for this population to inform treatment. Medical oncologists can refer their patients with high-grade serous ovarian cancer to this service for genetic testing. This study aimed to explore oncologists' experiences of using this telephone genetic counseling service for ..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council of Australia
Awarded by National Breast Cancer Foundation
We would like to thank all the oncologists who participated in this study. The evaluation of the telephone genetic counseling service is funded by a National Health and Medical Research Council (NHMRC) program grant (PI: A/Prof Paul James). Bettina Meiser was supported by a Senior Research Fellowship Level B from the National Health and Medical Research Council of Australia (ID 1078523). Laura Forrest is supported by a postdoctoral fellowship from the National Breast Cancer Foundation (14-009). This paper was completed as part of the Independent Learning Project by Pierre Hemming which contributed towards his medical degree at the University of New South Wales.